nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP2D6—Hydroxyurea—head and neck cancer	0.379	0.567	CbGbCtD
Oxymorphone—CYP2D6—Vinblastine—head and neck cancer	0.134	0.201	CbGbCtD
Oxymorphone—CYP3A4—Vinblastine—head and neck cancer	0.0852	0.128	CbGbCtD
Oxymorphone—CYP3A4—Docetaxel—head and neck cancer	0.0703	0.105	CbGbCtD
Oxymorphone—Cancer pain—Docetaxel—head and neck cancer	0.0486	0.146	CcSEcCtD
Oxymorphone—Ileus paralytic—Vinblastine—head and neck cancer	0.0171	0.0515	CcSEcCtD
Oxymorphone—Ileus—Vinblastine—head and neck cancer	0.0104	0.0314	CcSEcCtD
Oxymorphone—Disorientation—Hydroxyurea—head and neck cancer	0.00547	0.0165	CcSEcCtD
Oxymorphone—Ileus—Docetaxel—head and neck cancer	0.00494	0.0149	CcSEcCtD
Oxymorphone—Dermatitis atopic—Docetaxel—head and neck cancer	0.00473	0.0142	CcSEcCtD
Oxymorphone—Euphoric mood—Fluorouracil—head and neck cancer	0.00417	0.0126	CcSEcCtD
Oxymorphone—Disorientation—Fluorouracil—head and neck cancer	0.00393	0.0119	CcSEcCtD
Oxymorphone—Oliguria—Docetaxel—head and neck cancer	0.0038	0.0114	CcSEcCtD
Oxymorphone—Drug interaction—Docetaxel—head and neck cancer	0.00377	0.0114	CcSEcCtD
Oxymorphone—Amnesia—Fluorouracil—head and neck cancer	0.00375	0.0113	CcSEcCtD
Oxymorphone—Lethargy—Fluorouracil—head and neck cancer	0.00359	0.0108	CcSEcCtD
Oxymorphone—Injection site reaction—Docetaxel—head and neck cancer	0.00348	0.0105	CcSEcCtD
Oxymorphone—Hallucination—Hydroxyurea—head and neck cancer	0.00337	0.0101	CcSEcCtD
Oxymorphone—Angiopathy—Hydroxyurea—head and neck cancer	0.00307	0.00925	CcSEcCtD
Oxymorphone—Vertigo—Vinblastine—head and neck cancer	0.0029	0.00874	CcSEcCtD
Oxymorphone—Convulsion—Vinblastine—head and neck cancer	0.0028	0.00843	CcSEcCtD
Oxymorphone—Hypertension—Vinblastine—head and neck cancer	0.00279	0.0084	CcSEcCtD
Oxymorphone—Pneumonia—Fluorouracil—head and neck cancer	0.00273	0.00822	CcSEcCtD
Oxymorphone—Hot flush—Docetaxel—head and neck cancer	0.00272	0.00818	CcSEcCtD
Oxymorphone—Menopausal symptoms—Docetaxel—head and neck cancer	0.00269	0.00811	CcSEcCtD
Oxymorphone—Visual disturbance—Docetaxel—head and neck cancer	0.00268	0.00808	CcSEcCtD
Oxymorphone—Lethargy—Docetaxel—head and neck cancer	0.00259	0.00781	CcSEcCtD
Oxymorphone—Convulsion—Hydroxyurea—head and neck cancer	0.00255	0.00769	CcSEcCtD
Oxymorphone—Anorexia—Vinblastine—head and neck cancer	0.00251	0.00757	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00249	0.0075	CcSEcCtD
Oxymorphone—Oedema—Hydroxyurea—head and neck cancer	0.0024	0.00724	CcSEcCtD
Oxymorphone—Dehydration—Docetaxel—head and neck cancer	0.00236	0.00712	CcSEcCtD
Oxymorphone—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00236	0.0071	CcSEcCtD
Oxymorphone—Skin disorder—Hydroxyurea—head and neck cancer	0.00233	0.00703	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00232	0.00699	CcSEcCtD
Oxymorphone—Anorexia—Hydroxyurea—head and neck cancer	0.00229	0.0069	CcSEcCtD
Oxymorphone—Decreased appetite—Vinblastine—head and neck cancer	0.00229	0.0069	CcSEcCtD
Oxymorphone—Pain—Vinblastine—head and neck cancer	0.00225	0.00679	CcSEcCtD
Oxymorphone—Constipation—Vinblastine—head and neck cancer	0.00225	0.00679	CcSEcCtD
Oxymorphone—Feeling abnormal—Vinblastine—head and neck cancer	0.00217	0.00654	CcSEcCtD
Oxymorphone—Bronchospasm—Docetaxel—head and neck cancer	0.00216	0.00651	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00215	0.00649	CcSEcCtD
Oxymorphone—Dyspnoea—Hydroxyurea—head and neck cancer	0.00214	0.00646	CcSEcCtD
Oxymorphone—Somnolence—Hydroxyurea—head and neck cancer	0.00214	0.00644	CcSEcCtD
Oxymorphone—Dyspepsia—Hydroxyurea—head and neck cancer	0.00212	0.00637	CcSEcCtD
Oxymorphone—Decreased appetite—Hydroxyurea—head and neck cancer	0.00209	0.0063	CcSEcCtD
Oxymorphone—Abdominal pain—Vinblastine—head and neck cancer	0.00208	0.00628	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00207	0.00625	CcSEcCtD
Oxymorphone—Fatigue—Hydroxyurea—head and neck cancer	0.00207	0.00624	CcSEcCtD
Oxymorphone—Pain—Hydroxyurea—head and neck cancer	0.00206	0.00619	CcSEcCtD
Oxymorphone—Constipation—Hydroxyurea—head and neck cancer	0.00206	0.00619	CcSEcCtD
Oxymorphone—Vision blurred—Fluorouracil—head and neck cancer	0.002	0.00602	CcSEcCtD
Oxymorphone—Weight decreased—Docetaxel—head and neck cancer	0.00199	0.00599	CcSEcCtD
Oxymorphone—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00198	0.00597	CcSEcCtD
Oxymorphone—Pneumonia—Docetaxel—head and neck cancer	0.00197	0.00593	CcSEcCtD
Oxymorphone—Hypersensitivity—Vinblastine—head and neck cancer	0.00194	0.00585	CcSEcCtD
Oxymorphone—Body temperature increased—Hydroxyurea—head and neck cancer	0.0019	0.00572	CcSEcCtD
Oxymorphone—Asthenia—Vinblastine—head and neck cancer	0.00189	0.0057	CcSEcCtD
Oxymorphone—Convulsion—Fluorouracil—head and neck cancer	0.00184	0.00553	CcSEcCtD
Oxymorphone—Chest pain—Fluorouracil—head and neck cancer	0.0018	0.00544	CcSEcCtD
Oxymorphone—Diarrhoea—Vinblastine—head and neck cancer	0.0018	0.00543	CcSEcCtD
Oxymorphone—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00177	0.00534	CcSEcCtD
Oxymorphone—Confusional state—Fluorouracil—head and neck cancer	0.00174	0.00526	CcSEcCtD
Oxymorphone—Dizziness—Vinblastine—head and neck cancer	0.00174	0.00525	CcSEcCtD
Oxymorphone—Urinary tract disorder—Docetaxel—head and neck cancer	0.00174	0.00523	CcSEcCtD
Oxymorphone—Oedema—Fluorouracil—head and neck cancer	0.00173	0.00521	CcSEcCtD
Oxymorphone—Asthenia—Hydroxyurea—head and neck cancer	0.00172	0.0052	CcSEcCtD
Oxymorphone—Urethral disorder—Docetaxel—head and neck cancer	0.00172	0.00519	CcSEcCtD
Oxymorphone—Nervous system disorder—Fluorouracil—head and neck cancer	0.0017	0.00511	CcSEcCtD
Oxymorphone—Visual impairment—Docetaxel—head and neck cancer	0.00169	0.0051	CcSEcCtD
Oxymorphone—Tachycardia—Fluorouracil—head and neck cancer	0.00169	0.00509	CcSEcCtD
Oxymorphone—Vomiting—Vinblastine—head and neck cancer	0.00168	0.00505	CcSEcCtD
Oxymorphone—Headache—Vinblastine—head and neck cancer	0.00165	0.00497	CcSEcCtD
Oxymorphone—Anorexia—Fluorouracil—head and neck cancer	0.00165	0.00497	CcSEcCtD
Oxymorphone—Diarrhoea—Hydroxyurea—head and neck cancer	0.00164	0.00495	CcSEcCtD
Oxymorphone—Eye disorder—Docetaxel—head and neck cancer	0.00164	0.00495	CcSEcCtD
Oxymorphone—Flushing—Docetaxel—head and neck cancer	0.00163	0.00491	CcSEcCtD
Oxymorphone—Cardiac disorder—Docetaxel—head and neck cancer	0.00163	0.00491	CcSEcCtD
Oxymorphone—Hypotension—Fluorouracil—head and neck cancer	0.00162	0.00487	CcSEcCtD
Oxymorphone—Angiopathy—Docetaxel—head and neck cancer	0.00159	0.0048	CcSEcCtD
Oxymorphone—Dizziness—Hydroxyurea—head and neck cancer	0.00159	0.00479	CcSEcCtD
Oxymorphone—Immune system disorder—Docetaxel—head and neck cancer	0.00159	0.00478	CcSEcCtD
Oxymorphone—Mediastinal disorder—Docetaxel—head and neck cancer	0.00158	0.00477	CcSEcCtD
Oxymorphone—Nausea—Vinblastine—head and neck cancer	0.00157	0.00472	CcSEcCtD
Oxymorphone—Insomnia—Fluorouracil—head and neck cancer	0.00156	0.00471	CcSEcCtD
Oxymorphone—Dyspnoea—Fluorouracil—head and neck cancer	0.00154	0.00465	CcSEcCtD
Oxymorphone—Mental disorder—Docetaxel—head and neck cancer	0.00154	0.00464	CcSEcCtD
Oxymorphone—Somnolence—Fluorouracil—head and neck cancer	0.00154	0.00463	CcSEcCtD
Oxymorphone—Malnutrition—Docetaxel—head and neck cancer	0.00153	0.00461	CcSEcCtD
Oxymorphone—Vomiting—Hydroxyurea—head and neck cancer	0.00153	0.0046	CcSEcCtD
Oxymorphone—Dyspepsia—Fluorouracil—head and neck cancer	0.00152	0.00459	CcSEcCtD
Oxymorphone—Dermatitis—Hydroxyurea—head and neck cancer	0.00151	0.00456	CcSEcCtD
Oxymorphone—Headache—Hydroxyurea—head and neck cancer	0.00151	0.00454	CcSEcCtD
Oxymorphone—Decreased appetite—Fluorouracil—head and neck cancer	0.0015	0.00453	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00149	0.0045	CcSEcCtD
Oxymorphone—Pain—Fluorouracil—head and neck cancer	0.00148	0.00446	CcSEcCtD
Oxymorphone—Nausea—Hydroxyurea—head and neck cancer	0.00143	0.0043	CcSEcCtD
Oxymorphone—Feeling abnormal—Fluorouracil—head and neck cancer	0.00143	0.0043	CcSEcCtD
Oxymorphone—Urticaria—Fluorouracil—head and neck cancer	0.00137	0.00414	CcSEcCtD
Oxymorphone—Syncope—Docetaxel—head and neck cancer	0.00137	0.00413	CcSEcCtD
Oxymorphone—Body temperature increased—Fluorouracil—head and neck cancer	0.00137	0.00412	CcSEcCtD
Oxymorphone—Palpitations—Docetaxel—head and neck cancer	0.00135	0.00407	CcSEcCtD
Oxymorphone—Loss of consciousness—Docetaxel—head and neck cancer	0.00134	0.00405	CcSEcCtD
Oxymorphone—Convulsion—Docetaxel—head and neck cancer	0.00133	0.00399	CcSEcCtD
Oxymorphone—Hypertension—Docetaxel—head and neck cancer	0.00132	0.00398	CcSEcCtD
Oxymorphone—Chest pain—Docetaxel—head and neck cancer	0.0013	0.00392	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00129	0.0039	CcSEcCtD
Oxymorphone—Hypersensitivity—Fluorouracil—head and neck cancer	0.00127	0.00384	CcSEcCtD
Oxymorphone—Dry mouth—Docetaxel—head and neck cancer	0.00127	0.00384	CcSEcCtD
Oxymorphone—Confusional state—Docetaxel—head and neck cancer	0.00126	0.00379	CcSEcCtD
Oxymorphone—Oedema—Docetaxel—head and neck cancer	0.00125	0.00376	CcSEcCtD
Oxymorphone—Shock—Docetaxel—head and neck cancer	0.00123	0.0037	CcSEcCtD
Oxymorphone—Nervous system disorder—Docetaxel—head and neck cancer	0.00122	0.00369	CcSEcCtD
Oxymorphone—Pruritus—Fluorouracil—head and neck cancer	0.00122	0.00369	CcSEcCtD
Oxymorphone—Tachycardia—Docetaxel—head and neck cancer	0.00122	0.00367	CcSEcCtD
Oxymorphone—Skin disorder—Docetaxel—head and neck cancer	0.00121	0.00365	CcSEcCtD
Oxymorphone—Anorexia—Docetaxel—head and neck cancer	0.00119	0.00359	CcSEcCtD
Oxymorphone—Diarrhoea—Fluorouracil—head and neck cancer	0.00118	0.00357	CcSEcCtD
Oxymorphone—Hypotension—Docetaxel—head and neck cancer	0.00117	0.00352	CcSEcCtD
Oxymorphone—Dizziness—Fluorouracil—head and neck cancer	0.00114	0.00345	CcSEcCtD
Oxymorphone—Insomnia—Docetaxel—head and neck cancer	0.00113	0.0034	CcSEcCtD
Oxymorphone—Dyspnoea—Docetaxel—head and neck cancer	0.00111	0.00335	CcSEcCtD
Oxymorphone—Somnolence—Docetaxel—head and neck cancer	0.00111	0.00334	CcSEcCtD
Oxymorphone—Vomiting—Fluorouracil—head and neck cancer	0.0011	0.00331	CcSEcCtD
Oxymorphone—Dyspepsia—Docetaxel—head and neck cancer	0.0011	0.00331	CcSEcCtD
Oxymorphone—Dermatitis—Fluorouracil—head and neck cancer	0.00109	0.00328	CcSEcCtD
Oxymorphone—Decreased appetite—Docetaxel—head and neck cancer	0.00109	0.00327	CcSEcCtD
Oxymorphone—Headache—Fluorouracil—head and neck cancer	0.00108	0.00327	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00108	0.00325	CcSEcCtD
Oxymorphone—Fatigue—Docetaxel—head and neck cancer	0.00108	0.00324	CcSEcCtD
Oxymorphone—Pain—Docetaxel—head and neck cancer	0.00107	0.00322	CcSEcCtD
Oxymorphone—Constipation—Docetaxel—head and neck cancer	0.00107	0.00322	CcSEcCtD
Oxymorphone—Feeling abnormal—Docetaxel—head and neck cancer	0.00103	0.0031	CcSEcCtD
Oxymorphone—Nausea—Fluorouracil—head and neck cancer	0.00103	0.0031	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00102	0.00308	CcSEcCtD
Oxymorphone—Abdominal pain—Docetaxel—head and neck cancer	0.000987	0.00297	CcSEcCtD
Oxymorphone—Body temperature increased—Docetaxel—head and neck cancer	0.000987	0.00297	CcSEcCtD
Oxymorphone—Hypersensitivity—Docetaxel—head and neck cancer	0.00092	0.00277	CcSEcCtD
Oxymorphone—Asthenia—Docetaxel—head and neck cancer	0.000896	0.0027	CcSEcCtD
Oxymorphone—Pruritus—Docetaxel—head and neck cancer	0.000883	0.00266	CcSEcCtD
Oxymorphone—Diarrhoea—Docetaxel—head and neck cancer	0.000854	0.00257	CcSEcCtD
Oxymorphone—Dizziness—Docetaxel—head and neck cancer	0.000826	0.00249	CcSEcCtD
Oxymorphone—Vomiting—Docetaxel—head and neck cancer	0.000794	0.00239	CcSEcCtD
Oxymorphone—Dermatitis—Docetaxel—head and neck cancer	0.000787	0.00237	CcSEcCtD
Oxymorphone—Headache—Docetaxel—head and neck cancer	0.000782	0.00236	CcSEcCtD
Oxymorphone—Nausea—Docetaxel—head and neck cancer	0.000742	0.00223	CcSEcCtD
